AKROSWISS

akroswiss-logo

Akroswiss is a Swiss pharmaceutical company that is developing new intranasal formulations in CNS.

#SimilarOrganizations #People #Website #More

AKROSWISS

Social Links:

Industry:
Biotechnology Pharmaceutical

Founded:
2007-06-07

Address:
Zug, Zug, Switzerland

Country:
Switzerland

Website Url:
http://www.akroswiss.ch

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
3 M CHF

Technology used in webpage:
Organization Schema Person Schema U.S. Server Location


Similar Organizations

alvion-pharmaceuticals-pc-logo

Alvion Pharmaceuticals P.C.

Pharmaceutical company

amyndas-pharmaceuticals-sa-logo

Amyndas Pharmaceuticals S.A.

Amyndas is a pharmaceutical company

dayton-therapeutics-logo

Dayton Therapeutics

Pharmaceuticals, Biotech, Oncology

jenrin-discovery-logo

Jenrin Discovery

Jenrin Discovery is a biopharmaceutical Company.

mits-lifesciences-logo

Mits lifesciences

Pharmaceuticals company

novo-nordisk-pharmatech-logo

Novo Nordisk Pharmatech

Pharmaceutical company

palmira-biopharma-logo

Palmira Biopharma

Biopharmaceutical company

Current Employees Featured

john-fröhlich_image

John Fröhlich
John Fröhlich Founder & Chief Scientific Officer @ Akroswiss
Founder & Chief Scientific Officer

marc-fröhlich_image

Marc Fröhlich
Marc Fröhlich Chief Executive Officer @ Akroswiss
Chief Executive Officer

Founder


john-fröhlich_image

John Fröhlich

Official Site Inspections

http://www.akroswiss.ch Semrush global rank: 7.35 M Semrush visits lastest month: 805

  • Host name: 147.62.236.23.bc.googleusercontent.com
  • IP address: 23.236.62.147
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "Akroswiss"

Pharmaceutical company | Akroswiss | Zug

May 17, 2021 Due to its heritage in MRI research, Akroswiss is focusing primarily on the claustrophobia problematic encountered at MRI examinations. In Europe about 50 million MRI scans are performed annually and about 10-20% …See details»

Akroswiss - Crunchbase Company Profile & Funding

Organization. Akroswiss . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email …See details»

Akroswiss - LinkedIn

Akroswiss is a swiss based pharmaceutical company, fully dedicated to the development and commercialization of innovative nasal applications of midazolam.See details»

AKROSWISS AG Company Profile | Zug, ZUG, Switzerland

Find company research, competitor information, contact details & financial data for AKROSWISS AG of Zug, ZUG. Get the latest business insights from Dun & Bradstreet.See details»

Akroswiss Company Profile 2025: Valuation, Funding & Investors

Www.akroswiss.ch. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. Baarerstrasse 2; 6300 Zug; Switzerland ... Bernhard Schuknecht, …See details»

Akroswiss takes a step forward in the interest of patients closing a ...

May 17, 2021 Akroswiss has successfully developed and tested a unique Bi-dose nasal drug delivery device for Midazolam with a first-class 360° functionality. The development of these …See details»

Akroswiss AG - startup.ch

Akroswiss AG: Akroswiss aims to develop, manufacture, and commercialize innovative nasal treatments in CNS. We are pursuing EMA marketing authorization for our two indications in …See details»

AKROSWISS, A World Intellectual Property Organization …

AKROSWISS is a WIPO trademark and brand of AKROSWISS AG, Baarerstrasse 2, CH-6300 Zug,SWITZERLAND. This trademark was filed to WIPO on Tuesday, April 4, 2023. The …See details»

Akroswiss - Overview, News & Similar companies | ZoomInfo.com

Akroswiss Closes Multi-Million CHF Seed Funding Round Akroswiss, a Zug, Switzerland-based developer of an innovative and patented Midazolam-based nasal spray to treat patients …See details»

Akroswiss AG - Drug pipelines, Patents, Clinical trials - Synapse

Explore Akroswiss AG with its drug pipeline, therapeutic area, technology platform, .See details»

Akroswiss Overview | SignalHire Company Profile

Akroswiss is a swiss based pharmaceutical company, fully dedicated to the development and commercialization of innovative nasal applications of midazolam. ... Organization Website. …See details»

AKROSWISS AG :: Switzerland :: OpenCorporates

Free and open company data on Switzerland company AKROSWISS AG (company number 855982), Baarerstrasse, 2, Zug, 6300. Learn how to leverage transparent company data at …See details»

Akroswiss - Products, Competitors, Financials, Employees, …

May 18, 2021 Akroswiss is a pharmaceutical company focused on the development of innovative nasal treatments in the central nervous system (CNS) domain. The company specializes in …See details»

Akroswiss' Leadership Team Team - Team members and org chart

The Akroswiss leadership team has a wealth of experience in various industries, including management consulting, finance, and accounting. The team members have also received …See details»

Start-up develops nasal spray against fear - ZUG4YOU

The so-called seed financing was provided by Akroswiss AG, based in Zug, which also manages the licensing rights. Akroswiss employs only a handful of people, but relies on many external …See details»

News - Akroswiss

Akroswiss takes a step forward in the interest of patients closing a multi-million CHF funding round. ZUG, Switzerland: May 17, 2021 Akroswiss is developing an innovative and patented …See details»

Akroswiss - Contacts, Employees, Board Members, Advisors

Organization. Akroswiss . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. Akroswiss has 2 …See details»

Akroswiss gets funding for development of midazolam nasal spray …

May 17, 2021 Akroswiss bi-dose spray is easy to administer and more hygienic than any other solution. Relief of anxiety by endonasal administration is a safe, effective route to improve …See details»

Akroswiss Closes Multi-Million CHF Seed Funding Round - FinSMEs

May 18, 2021 Akroswiss, a Zug, Switzerland-based developer of an innovative and patented Midazolam-based nasal spray to treat patients suffering from claustrophobia and epileptic …See details»

Akros AG - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Akros AG of Root, LUZERN. Get the latest business insights from Dun & Bradstreet.See details»

linkstock.net © 2022. All rights reserved